Back to top

EVA/LACOG 0123 | GOG-3043 – ROCC Trial

  /    /  EVA/LACOG 0123 | GOG-3043 – ROCC Trial

A Randomized Controlled Trial of Robotic versus Open Surgery for Early Stage Cervical Cancer (ROCC trial)

Type of Study: Clinical

Sponsor and Funding: GOG Foundation and Intuitive Foundation

Lead Group: GOG Foundation

Collaborative Groups: LACOG and EVA Group

Primary objectives: To compare the 3-year disease-free survival (DFS) for patients who undergo robotic assisted laparoscopy versus open hysterectomy and lymph node assessment for the treatment of early stage uterine cervical cancer.

Principal Investigator Lead (Brazil): Glauco Baiocchi Neto

Countries: Brazil, Canada, United States

ClinicalTrials.gov Identifier: NCT04831580

The study is open to patients participation in the following research sites:

A.C. Camargo Cancer Center / São Paulo / SP / Brazil